C WorldWide Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

C WorldWide Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,446	Closed	-$183K	–	134
2018 Q3	$183K	Buy	1,446 +202	+16%	+$21.4K	﹤0.01%	127
2018 Q2	$104K	Hold	1,244	–	–	﹤0.01%	129
2018 Q1	$77K	Sell	1,244 -40	-3%	-$2.41K	﹤0.01%	126
2017 Q4	$75K	Sell	1,284 -133	-9%	-$8.39K	﹤0.01%	123
2017 Q3	$82K	Buy	1,417 +201	+17%	+$21.6K	﹤0.01%	126
2017 Q2	$147K	Sell	1,216 -107	-8%	-$12.4K	﹤0.01%	125
2017 Q1	$150K	Sell	1,323 -116	-8%	-$13.5K	﹤0.01%	125
2016 Q4	$156K	Sell	1,439 -2,361	-62%	-$281K	﹤0.01%	119
2016 Q3	$625K	Hold	3,800	–	–	0.01%	117
2016 Q2	$542K	Hold	3,800	–	–	0.01%	108
2016 Q1	$488K	Hold	3,800	–	–	0.01%	113
2015 Q4	$568K	Buy	3,800 +440	+13%	+$74.5K	0.01%	122
2015 Q3	$557K	Buy	3,360 +60	+2%	+$13.2K	0.01%	123
2015 Q2	$797K	Buy	+3,300	New	+$879K	0.01%	115

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

C WorldWide Group's ICPT Position: Q4 2018 in Review

C WorldWide Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2018, closing a stake of 1,446 shares — an estimated $183K sold.

C WorldWide Group first reported a position in ICPT in Q2 2015 and held it in 14 quarters. The position peaked at $797K in Q2 2015. 191 funds tracked by Wall St. Rank hold ICPT as of Q4 2018.

C WorldWide Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
C WorldWide Group sold 1,446 Intercept Pharmaceuticals, Inc. shares in Q4 2018, an estimated $183K.
C WorldWide Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 14 quarters.
C WorldWide Group's Intercept Pharmaceuticals, Inc. position peaked at $797K in Q2 2015.
191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2018.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.